Upadacitinib for Refractory Prurigo Nodularis: A Case Series and Literature Review
Clinical, Cosmetic and Investigational Dermatology · 2026-11 · Volume 19 · 1-12
DOI: 10.2147/ccid.s651906 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2026-11. Verfasst von Yaqing Wen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sexually Transmitted Disease, Center of Infectious Skin Disease, Shanghai Skin Disease Hospital, School of Medicine, Tongji University,…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Sexually Transmitted Disease, Center of Infectious Skin Disease, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
ORCID-Profile: Yuanyuan Cheng
Zitieren
APA
Wen, Y., Chen, Z., Zheng, X., Cheng, Y., Liao, C., Peng, R. R., & Long, F. Q. (2026). Upadacitinib for Refractory Prurigo Nodularis: A Case Series and Literature Review. Clinical, Cosmetic and Investigational Dermatology, Volume 19, 1-12. https://doi.org/10.2147/ccid.s651906
Vancouver
Wen Y, Chen Z, Zheng X, Cheng Y, Liao C, Peng RR, et al. Upadacitinib for Refractory Prurigo Nodularis: A Case Series and Literature Review. Clinical, Cosmetic and Investigational Dermatology. 2026;Volume 19:1-12. doi:10.2147/ccid.s651906
BibTeX
@article{Wen2026,
author = {Wen, Yaqing and Chen, Zuoxi and Zheng, Xin and Cheng, Yuanyuan and Liao, Chunjie and Peng, Rui-Rui and Long, Fu-Quan},
title = {Upadacitinib for Refractory Prurigo Nodularis: A Case Series and Literature Review},
journal = {Clinical, Cosmetic and Investigational Dermatology},
year = {2026},
volume = {Volume 19},
pages = {1--12},
doi = {10.2147/ccid.s651906}
}
EUVIMED